GPR55 and depressive symptom measurement: There is evidence that GPR55 plays an important role in depression; a 7-day intravenous (i.v.)treatment with the GPR55-agonist O-1602 decreased despair-like behavior in female rats subjected to a 14-day corticosterone treatment [125].